Supplemental Consolidating Data - Cash Flows (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 27, 2020	Jun. 28, 2020	Mar. 29, 2020	Sep. 29, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 27, 2020	Sep. 29, 2019
Cash flows from operating activities:
Net income	$ 120,218	$ (92,217)	$ 69,695	$ 86,563	$ 195,631	$ 127,945	$ 97,696	$ 410,139
Adjustments to reconcile Net income to Net cash provided by operating activities:
Depreciation and amortization							140,057	174,609
Amortization of deferred loan origination costs							52,374	57,303
Amortization of financing origination fees							10,628	7,032
Provision for long-term employee benefits							23,557	10,888
Employee benefit plan contributions and payments							(5,456)	(11,166)
Stock compensation expense							12,076	25,323
Net change in wholesale finance receivables related to sales							330,793	683
Provision for credit losses	7,835			33,747			178,433	94,621
Deferred income taxes							(18,978)	3,535
Other, net							(9,320)	7,839
Changes in current assets and liabilities:
Accounts receivable, net							29,630	(7,833)
Finance receivables – accrued interest and other							5,097	(4,574)
Inventories, net							273,668	62,870
Accounts payable and accrued liabilities							(16,922)	13,138
Derivative financial instruments							(1,543)	2,537
Other							33,278	1,705
Total adjustments							1,037,372	438,510
Net cash provided by operating activities							1,135,068	848,649
Cash flows from investing activities:
Capital expenditures							(92,295)	(121,161)
Origination of finance receivables							(2,873,259)	(3,141,626)
Collections on finance receivables							2,730,166	2,695,918
Sales and redemptions of marketable securities							0	10,007
Acquisition of business							0	(7,000)
Other investing activities							334	12,388
Net cash used by investing activities							(235,054)	(551,474)
Cash flows from financing activities:
Proceeds from issuance of medium-term notes							1,396,602	546,655
Repayments of medium-term notes							(1,400,000)	(1,350,000)
Proceeds from securitization debt							2,064,450	1,021,353
Repayments of securitization debt							(735,885)	(244,250)
Borrowings of asset-backed commercial paper							225,187	177,950
Repayments of asset-backed commercial paper							(236,846)	(240,008)
Net increase in unsecured commercial paper							509,978	(120,707)
Net increase in credit facilities							150,000	0
Deposits							29,992	0
Dividends paid							(65,002)	(179,409)
Repurchase of common stock							(7,895)	(217,454)
Issuance of common stock under share-based plans							96	2,180
Net cash provided (used) by financing activities							1,930,677	(603,690)
Effect of exchange rate changes on cash, cash equivalents and restricted cash							6,071	(4,110)
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period			905,366			1,259,748	905,366	1,259,748
Net increase (decrease) in cash, cash equivalents and restricted cash							2,836,762	(310,625)
Cash, cash equivalents and restricted cash, end of period	3,742,128			949,123			3,742,128	949,123
HDMC Entities
Cash flows from financing activities:
Proceeds from securitization debt							0
HDFS Entities
Cash flows from financing activities:
Proceeds from securitization debt							2,064,450
Reportable Legal Entities | HDMC Entities
Cash flows from operating activities:
Net income	50,584			82,705			106,047	396,320
Adjustments to reconcile Net income to Net cash provided by operating activities:
Depreciation and amortization							133,679	168,013
Amortization of deferred loan origination costs							0	0
Amortization of financing origination fees							510	503
Provision for long-term employee benefits							23,557	10,888
Employee benefit plan contributions and payments							(5,456)	(11,166)
Stock compensation expense							10,959	22,869
Net change in wholesale finance receivables related to sales							0	0
Provision for credit losses	0			0			0	0
Deferred income taxes							6,171	5,514
Other, net							(13,628)	9,126
Changes in current assets and liabilities:
Accounts receivable, net							(100,672)	(216,961)
Finance receivables – accrued interest and other							0	0
Inventories, net							273,668	62,870
Accounts payable and accrued liabilities							(38,815)	8,729
Derivative financial instruments							(1,584)	2,443
Other							26,704	(19,516)
Total adjustments							315,093	43,312
Net cash provided by operating activities							421,140	439,632
Cash flows from investing activities:
Capital expenditures							(90,592)	(118,182)
Origination of finance receivables							0	0
Collections on finance receivables							0	0
Sales and redemptions of marketable securities								10,007
Acquisition of business								(7,000)
Other investing activities							334	12,388
Net cash used by investing activities							(90,258)	(102,787)
Cash flows from financing activities:
Proceeds from issuance of medium-term notes							0	0
Repayments of medium-term notes							0	0
Proceeds from securitization debt								0
Repayments of securitization debt							0	0
Borrowings of asset-backed commercial paper							0	0
Repayments of asset-backed commercial paper							0	0
Net increase in unsecured commercial paper							0	0
Net increase in credit facilities							0
Deposits							0
Dividends paid							(65,002)	(179,409)
Repurchase of common stock							(7,895)	(217,454)
Issuance of common stock under share-based plans							96	2,180
Net cash provided (used) by financing activities							(72,801)	(394,683)
Effect of exchange rate changes on cash, cash equivalents and restricted cash							4,974	(4,604)
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period			470,649			544,548	470,649	544,548
Net increase (decrease) in cash, cash equivalents and restricted cash							263,055	(62,442)
Cash, cash equivalents and restricted cash, end of period	733,704			482,106			733,704	482,106
Reportable Legal Entities | HDFS Entities
Cash flows from operating activities:
Net income	69,915			53,999			91,542	153,905
Adjustments to reconcile Net income to Net cash provided by operating activities:
Depreciation and amortization							6,378	6,596
Amortization of deferred loan origination costs							52,374	57,303
Amortization of financing origination fees							10,118	6,529
Provision for long-term employee benefits							0	0
Employee benefit plan contributions and payments							0	0
Stock compensation expense							1,117	2,454
Net change in wholesale finance receivables related to sales							0	0
Provision for credit losses	7,835			33,747			178,433	94,621
Deferred income taxes							(24,737)	(1,765)
Other, net							4,416	(1,372)
Changes in current assets and liabilities:
Accounts receivable, net							0	0
Finance receivables – accrued interest and other							5,097	(4,574)
Inventories, net							0	0
Accounts payable and accrued liabilities							154,121	207,971
Derivative financial instruments							41	94
Other							2,634	12,144
Total adjustments							389,992	380,001
Net cash provided by operating activities							481,534	533,906
Cash flows from investing activities:
Capital expenditures							(1,703)	(2,979)
Origination of finance receivables							(4,697,675)	(5,757,384)
Collections on finance receivables							4,886,976	5,326,787
Sales and redemptions of marketable securities								0
Acquisition of business								0
Other investing activities							0	0
Net cash used by investing activities							187,598	(433,576)
Cash flows from financing activities:
Proceeds from issuance of medium-term notes							1,396,602	546,655
Repayments of medium-term notes							(1,400,000)	(1,350,000)
Proceeds from securitization debt								1,021,353
Repayments of securitization debt							(735,885)	(244,250)
Borrowings of asset-backed commercial paper							225,187	177,950
Repayments of asset-backed commercial paper							(236,846)	(240,008)
Net increase in unsecured commercial paper							509,978	(120,707)
Net increase in credit facilities							150,000
Deposits							29,992
Dividends paid							(100,000)	(140,000)
Repurchase of common stock							0	0
Issuance of common stock under share-based plans							0	0
Net cash provided (used) by financing activities							1,903,478	(349,007)
Effect of exchange rate changes on cash, cash equivalents and restricted cash							1,097	494
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period			434,717			715,200	434,717	715,200
Net increase (decrease) in cash, cash equivalents and restricted cash							2,573,707	(248,183)
Cash, cash equivalents and restricted cash, end of period	3,008,424			467,017			3,008,424	467,017
Consolidating Adjustments
Cash flows from operating activities:
Net income	(281)			(50,141)			(99,893)	(140,086)
Adjustments to reconcile Net income to Net cash provided by operating activities:
Depreciation and amortization							0	0
Amortization of deferred loan origination costs							0	0
Amortization of financing origination fees							0	0
Provision for long-term employee benefits							0	0
Employee benefit plan contributions and payments							0	0
Stock compensation expense							0	0
Net change in wholesale finance receivables related to sales							330,793	683
Provision for credit losses	0			0			0	0
Deferred income taxes							(412)	(214)
Other, net							(108)	85
Changes in current assets and liabilities:
Accounts receivable, net							130,302	209,128
Finance receivables – accrued interest and other							0	0
Inventories, net							0	0
Accounts payable and accrued liabilities							(132,228)	(203,562)
Derivative financial instruments							0	0
Other							3,940	9,077
Total adjustments							332,287	15,197
Net cash provided by operating activities							232,394	(124,889)
Cash flows from investing activities:
Capital expenditures							0	0
Origination of finance receivables							1,824,416	2,615,758
Collections on finance receivables							(2,156,810)	(2,630,869)
Sales and redemptions of marketable securities								0
Acquisition of business								0
Other investing activities							0	0
Net cash used by investing activities							(332,394)	(15,111)
Cash flows from financing activities:
Proceeds from issuance of medium-term notes							0	0
Repayments of medium-term notes							0	0
Proceeds from securitization debt							0	0
Repayments of securitization debt							0	0
Borrowings of asset-backed commercial paper							0	0
Repayments of asset-backed commercial paper							0	0
Net increase in unsecured commercial paper							0	0
Net increase in credit facilities							0
Deposits							0
Dividends paid							100,000	140,000
Repurchase of common stock							0	0
Issuance of common stock under share-based plans							0	0
Net cash provided (used) by financing activities							100,000	140,000
Effect of exchange rate changes on cash, cash equivalents and restricted cash							0	0
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period			$ 0			$ 0	0	0
Net increase (decrease) in cash, cash equivalents and restricted cash							0	0
Cash, cash equivalents and restricted cash, end of period	$ 0			$ 0			$ 0	$ 0